Blood-Based Screening for Colorectal Cancer: Benefits and Limitations episode artwork

EPISODE · Apr 30, 2026 · 3 MIN

Blood-Based Screening for Colorectal Cancer: Benefits and Limitations

from Clinician's Roundtable

Guest: Aasma Shaukat, MD, MPH Despite available options like stool-based testing and colonoscopy, colorectal cancer screening rates remain low. Blood-based testing, however, has the potential to improve adherence by offering a convenient alternative. Join Dr. Aasma Shaukat as she discusses the clinical performance of blood-based testing, its limitations, and its role in real-world settings. Dr. Shaukat is the Robert M. and Mary H. Glickman Professor of Medicine and a Professor in the Department of Population Health at NYU Grossman School of Medicine. She also serves as the Director of Outcomes Research in the Division of Gastroenterology and Hepatology at NYU Langone Health.

Episode metadata supplied by the publisher feed · Published Apr 30, 2026

Embed this episode

NOW PLAYING

Blood-Based Screening for Colorectal Cancer: Benefits and Limitations

0:00 3:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinician's Roundtable?

This episode is 3 minutes long.

When was this Clinician's Roundtable episode published?

This episode was published on April 30, 2026.

Can I download this Clinician's Roundtable episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!